TECH
BIO-TECHNE Corp
Biological Products, (No Diagnostic Substances)- 売上
- $1.2bn
- 時価総額
- $11.4bn
株価 $72.03 · 100株 7,203円
| 期 | 23/06 | 24/06 | 25/06 |
|---|---|---|---|
| 売上 | $1.1bn | $1.2bn | $1.2bn |
| 成長率 | — | 2.0% | 5.2% |
| 総利益 | $770m | $770m | $790m |
| 総利益率 | 67.7% | 66.4% | 64.8% |
| 販管費 | $378m | $466m | $589m |
| 販管費率 | 33.3% | 40.2% | 48.3% |
| 営利 | $299m | $207m | $102m |
| 営利率 | 26.3% | 17.8% | 8.4% |
| 純利益 | $285m | $168m | $73m |
| PBR | 5.8 | 5.5 | 6.0 |
| PSR | 10.1 | 9.9 | 9.4 |
| PGPR | 14.8 | 14.8 | 14.5 |
| PER | 40 | 68 | 156 |
| ﾈｯﾄｷｬｯｼｭ | ▲$169m | ▲$167m | ▲$184m |
| EV/EBITDA | 28.5 | 36.4 | 54.7 |
| Rule of 40 | — | 20% | 14% |
| セールス効率 | — | ▲0% | 17% |
※Rule of 40は売上成長率＋営業利益率、セールス効率は売上総利益増加÷販管費増加（販管費増のときのみ）